Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
1. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79:8–15.
2. Besler C, Heinrich K, Riwanto M, et al. High-density lipoprotein- mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease. Curr Pharm Des. 2010;16:1480–93.
3. Kastelein JJ, van Leuven SI, Burgess L, et al. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med. 2007;356:1620–30.
4. Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459–67.
5. Paramsothy P, Knopp RH, Bertoni AG, et al. Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2010;56:1034–41.
6. Chambless LE, Folsom AR, Davis V, et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987–1998. Am J Epidemiol. 2002;155:38–47.
7. Hovingh GK, de Groot E, van der Steeg W, Boekholdt SM, Hutten BA, Kuivenhoven JA, et al. Inherited disorders of HDL metabolism and atherosclerosis. Curr Opin Lipidol. 2005;16(2):139–45.
8. Taylor AJ, Sullenberger LE, Lee HJ, et al. Arterial biology for the investigation of the treatment effect of reducing cholesterol (ARBITER) 2. A double-blind, placebo controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation. 2004;110:3512–7.
9. Taylor AJ, Lee HJ, Sullenberg LE. The effect of 24 months of combination statin and extended-release niacin on carotid intima- media thickness: ARBITER 3. Curr Med Res Opin. 2006;22:2243–50.
10. •• Taylor AJ, Villines TC, Stanek EJ, et al.: Extended-release niacin or ezetimibe and carotid intima–media thickness. N Engl J Med 2009, 361:2113–2122. This ultrasound CIMT study shows that raising HDL-C with niacin is more effective than lowering LDL-C with ezetimibe for decreasing atherosclerosis progression.
11. Blankenhorn DH, Selzer RH, Crawford DW, et al. Beneficial effects of cholestipol-niacin therapy on common carotid artery. Two- and four-year reduction in intima-media thickness measured by ultrasound. Circulation. 1993;88:20–8.
12. Mack WJ, Selzer RH, Hodis HN, et al. One-year reduction and longitudinal analyses of carotid intima-media thickness associated with colestipol/niacin therapy. Stroke. 1993;24:1779–83.
13. Bots ML, Visseren FL, Evans GW, et al. RADIANCE 2 Investigators. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. Lancet. 2007;370:153–60.
14. Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007;357:2109–22.
15. Vergeer M, Bots ML, van Leuven SI, et al. Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials. Circulation. 2008;118:2515–22.
16. Yuan C, Beach KW, Smith Jr LH, et al. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation. 1998;98:2666–71.
17. Duivenvoorden R, de Groot E, Elsen BM, et al. In vivo quantification of carotid artery wall dimensions: 3.0-Tesla MRI versus B-mode ultrasound imaging. Circ Cardiovasc Imaging. 2009;2:235–42.
18. Li F, Yarnykh VL, Hatsukami TS, et al. Scan-rescan reproducibility of carotid atherosclerotic plaque morphology and tissue composition measurements using multicontrast MRI at 3 T. J Magn Reson Imaging. 2010;31:168–76.
19. Underhill HR, Yuan C, Yarnykh VL, et al. Predictors of surface disruption with MR imaging in asymptomatic carotid artery stenosis. Am J Neuroradiol. 2009;31:487–93.
20. Takaya N, Yuan C, Chu B, et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI: initial results. Stroke. 2006;37:818–23.
21. Altaf N, Daniels L, Morgan PS, et al. Detection of intraplaque hemorrhage by magnetic resonance imaging in symptomatic patients with mild to moderate carotid stenosis predicts recurrent neurological events. J Vasc Surg. 2008;47:337–42.
22. • Parmar JP, Rogers WJ, Mugler JP 3 rd, et al.: Magnetic resonance imaging of carotid atherosclerotic plaque in clinically suspected acute transient ischemic attack and acute ischemic stroke. Circulation 2010, 122:2031–2038. This MRI study shows that American Heart Association plaque type 6 is highly predictive of TIA/stroke at the moment of onset of symptoms.
23. 
24. • Holleboom AG, Duivenvoorden R, van den Bogaard B, et al.: Patients with Low Plasma High Density Lipoprotein-Cholesterol due to Mutations in the Gene Encoding for Lecithin: Cholesterol Acyl Transferase have Increased Atherosclerosis: A 3.0 Tesla MRI Study. Circulation 2010, 122:A17773. This MRI study shows that carriers of LCAT gene mutations have increased atherosclerosis.
25. Wagenknecht L, Wasserman B, Chambless L, et al. Correlates of carotid plaque presence and composition as measured by MRI: the Atherosclerosis Risk in Communities Study. Circ Cardiovasc Imaging. 2009;2:314–22.
26. Wasserman BA, Sharrett AR, Lai S, et al. Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the multi-ethnic study of atherosclerosis (MESA). Stroke. 2008;39:329–35.
27. Lee JM, Robson MD, Yu LM, et al. Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. J Am Coll Cardiol. 2009;54:1787–94.
28. Zhao XQ, Phan BA, Chu B, et al. Testing the hypothesis of atherosclerotic plaque lipid depletion during lipid therapy by magnetic resonance imaging: study design of Carotid Plaque Composition Study. Am Heart J. 2007;154:239–46.
29. Donald AE, Halcox JP, Charakida M, et al. Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. J Am Coll Cardiol. 2008;51:1959–64.
30. Yeboah J, Crouse JR, Hsu FC, et al. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation. 2007;115:2390–7.